We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGNW
526
DELISTED
Origin Materials Inc Warrants
ORGNW
$1.89K ﹤0.01%
50,100
+100
+0.2% +$6
NRACW
527
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$1.87K ﹤0.01%
183,556
+43,725
+31% +$927
ABPWW
528
DELISTED
Abpro Holdings Warrant
ABPWW
$1.79K ﹤0.01%
89,127
-52,073
-37% -$2.36K
ZAPPW
529
DELISTED
Zapp Electric Vehicles Group Limited Warrant
ZAPPW
$1.78K ﹤0.01%
241,304
+211,304
+704% +$1.9K
HOVRW icon
530
New Horizon Aircraft Ltd
HOVRW
$12.5M
$1.77K ﹤0.01%
25,300
-100
-0.4% -$4
QDROW
531
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$1.74K ﹤0.01%
99,122
+95
+0.1% +$4
TCOA.WS
532
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$1.73K ﹤0.01%
43,614
-5,986
-12% -$369
OSRHW
533
OSR Health Warrant
OSRHW
$351K
$1.71K ﹤0.01%
85,750
FEXDW
534
DELISTED
Fintech Ecosystem Development Corp. Warrant
FEXDW
$1.7K ﹤0.01%
182,580
+132,580
+265% +$3.12K
CREVW
535
DELISTED
Carbon Revolution PLC Warrant
CREVW
$1.65K ﹤0.01%
+30,000
New +$2.03K
SEDA.WS
536
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$1.57K ﹤0.01%
50,000
USCTW
537
DELISTED
Roth CH Acquisition Co. Warrant
USCTW
$1.55K ﹤0.01%
61,850
+50
+0.1% +$2
SWVLW icon
538
Swvl Holdings Corp Warrant
SWVLW
$1.54K ﹤0.01%
232,903
+200
+0.1% +$2
IRAAW
539
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$1.5K ﹤0.01%
50,000
-4,000
-7% -$129
CLVRW
540
DELISTED
Clever Leaves Holdings Inc. Warrant
CLVRW
$1.49K ﹤0.01%
+84,333
New +$1.27K
LFLYW
541
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$1.49K ﹤0.01%
+94,146
New +$2.33K
SHPWW
542
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$1.42K ﹤0.01%
474,736
+121,615
+34% +$669
SBCWW
543
SBC Medical Group Warrants
SBCWW
$2.65M
$1.41K ﹤0.01%
50,000
-10,093
-17% -$405
COEPW
544
DELISTED
Coeptis Therapeutics Warrants
COEPW
$1.41K ﹤0.01%
+45,400
New +$1.78K
LIBYW
545
DELISTED
Liberty Resources Acquisition Corp. Warrant
LIBYW
$1.4K ﹤0.01%
280,171
+33,437
+14% +$859
ALSAR
546
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$1.3K ﹤0.01%
13,000
-600
-4% -$50
IRRX.WS
547
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
$1.3K ﹤0.01%
13,000
-29,992
-70% -$4.52K
FTIIW
548
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$1.3K ﹤0.01%
87,000
+42,537
+96% +$1.51K
GBBKW
549
DELISTED
Global Blockchain Acquisition Corp. Warrant
GBBKW
$1.27K ﹤0.01%
84,913
-100
-0.1% -$2
OCAXW
550
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$1.26K ﹤0.01%
20,000

Similar funds

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.